388 related articles for article (PubMed ID: 22482125)
1. Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.
Li W; Cooper J; Karajannis MA; Giancotti FG
EMBO Rep; 2012 Mar; 13(3):204-15. PubMed ID: 22482125
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into NF2/Merlin tumor suppressor function.
Cooper J; Giancotti FG
FEBS Lett; 2014 Aug; 588(16):2743-52. PubMed ID: 24726726
[TBL] [Abstract][Full Text] [Related]
3. Merlin, a multi-suppressor from cell membrane to the nucleus.
Zhou L; Hanemann CO
FEBS Lett; 2012 May; 586(10):1403-8. PubMed ID: 22595235
[TBL] [Abstract][Full Text] [Related]
4. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
[TBL] [Abstract][Full Text] [Related]
5. Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.
Hikasa H; Sekido Y; Suzuki A
Cell Rep; 2016 Mar; 14(12):2950-61. PubMed ID: 26997273
[TBL] [Abstract][Full Text] [Related]
6. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
Li W; Cooper J; Zhou L; Yang C; Erdjument-Bromage H; Zagzag D; Snuderl M; Ladanyi M; Hanemann CO; Zhou P; Karajannis MA; Giancotti FG
Cancer Cell; 2014 Jul; 26(1):48-60. PubMed ID: 25026211
[TBL] [Abstract][Full Text] [Related]
7. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.
Li Y; Zhou H; Li F; Chan SW; Lin Z; Wei Z; Yang Z; Guo F; Lim CJ; Xing W; Shen Y; Hong W; Long J; Zhang M
Cell Res; 2015 Jul; 25(7):801-17. PubMed ID: 26045165
[TBL] [Abstract][Full Text] [Related]
8. Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expression.
Cooper J; Li W; You L; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Sci Signal; 2011 Aug; 4(188):pt6. PubMed ID: 21878678
[TBL] [Abstract][Full Text] [Related]
9. Moesin-ezrin-radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus.
Chen H; Mei L; Zhou L; Zhang X; Guo C; Li J; Wang H; Zhu Y; Zheng Y; Huang L
Int J Biochem Cell Biol; 2011 Apr; 43(4):545-55. PubMed ID: 21167305
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of the binding of Merlin FERM domain to the E3 ubiquitin ligase substrate adaptor DCAF1.
Li Y; Wei Z; Zhang J; Yang Z; Zhang M
J Biol Chem; 2014 May; 289(21):14674-81. PubMed ID: 24706749
[TBL] [Abstract][Full Text] [Related]
11. Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).
Li W; Giancotti FG
Cell Cycle; 2010 Nov; 9(22):4433-6. PubMed ID: 21084862
[TBL] [Abstract][Full Text] [Related]
12. NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin.
Chiasson-MacKenzie C; Morris ZS; Baca Q; Morris B; Coker JK; Mirchev R; Jensen AE; Carey T; Stott SL; Golan DE; McClatchey AI
J Cell Biol; 2015 Oct; 211(2):391-405. PubMed ID: 26483553
[TBL] [Abstract][Full Text] [Related]
13. Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane.
Okada T; Lopez-Lago M; Giancotti FG
J Cell Biol; 2005 Oct; 171(2):361-71. PubMed ID: 16247032
[TBL] [Abstract][Full Text] [Related]
14. Cell-cell adhesion regulates Merlin/NF2 interaction with the PAF complex.
Roehrig AE; Klupsch K; Oses-Prieto JA; Chaib S; Henderson S; Emmett W; Young LC; Surinova S; Blees A; Pfeiffer A; Tijani M; Brunk F; Hartig N; Muñoz-Alegre M; Hergovich A; Jennings BH; Burlingame AL; Rodriguez-Viciana P
PLoS One; 2021; 16(8):e0254697. PubMed ID: 34424918
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 function.
Mori T; Gotoh S; Shirakawa M; Hakoshima T
Genes Cells; 2014 Aug; 19(8):603-19. PubMed ID: 24912773
[TBL] [Abstract][Full Text] [Related]
16. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
[TBL] [Abstract][Full Text] [Related]
17. NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.
Wei Y; Yee PP; Liu Z; Zhang L; Guo H; Zheng H; Anderson B; Gulley M; Li W
EMBO Rep; 2020 Dec; 21(12):e50642. PubMed ID: 33058421
[TBL] [Abstract][Full Text] [Related]
18. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.
Gladden AB; Hebert AM; Schneeberger EE; McClatchey AI
Dev Cell; 2010 Nov; 19(5):727-39. PubMed ID: 21074722
[TBL] [Abstract][Full Text] [Related]
19. Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling.
Kim S; Jho EH
BMB Rep; 2016 Jul; 49(7):357-8. PubMed ID: 27345717
[TBL] [Abstract][Full Text] [Related]
20. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
